Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Academic Research Proposals is sponsored by The High Q Foundation Inc.. CHDI Foundation (formerly The High Q Foundation Inc.) funds and collaborates with academic researchers worldwide to develop therapeutics for Huntington's disease. They seek novel ideas in specific thematic areas, prioritizing projects with robust human data or disease-modifying potential. Rather than traditional grants, CHDI enters into research contracts with investigators, providing financial support for personnel and consumables while maintaining active managerial involvement in the research plan.
Geographic focus: Global
Focus areas: Huntington's Disease, Targeting mutant huntingtin DNA, RNA, and protein, Somatic instability and mismatch handling/repair mechanisms, Therapeutic gene editing, Non-mismatch repair genetic modifiers
Official opportunity description and requirements excerpt:
Academic Proposals | CHDI Foundation Accelerating Therapeutic Development for Huntington's Disease Research tools & reagents Data sharing & infomatics Preclinical informatics: HDinHD External Partnership Proposals Independent Statistical Standing Committee Clinical outcomes: Rating scales Field guide to HD mouse models HD Therapeutics Conference Data, Reagents, and Biomaterials Sharing Policy Reimbursement of Publication Costs Financial Support for Conferences, Meetings, or Workshops Research tools & reagents Data sharing & infomatics Preclinical informatics: HDinHD External Partnership Proposals Independent Statistical Standing Committee Clinical outcomes: Rating scales Field guide to HD mouse models HD Therapeutics Conference Data, Reagents, and Biomaterials Sharing Policy Reimbursement of Publication Costs Financial Support for Conferences, Meetings, or Workshops CHDI Foundation is exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of individuals with HD. To prioritize where our resources will be most effective in HD therapeutic development, we have organized our preclinical research programs into four interconnected Thematic Areas that focus on what we consider the most promising therapeutic areas and the means to pharmacologically interrogate them; namely 1) targeting mutant huntingtin DNA, RNA, and protein, 2) targeting somatic instability and mismatch handling and repair mechanisms related to modifier genes, 3) targeting the non-mismatch repair genetic modifiers, and 4) targeting gene editing of the causative triplet repeat mutation in the huntingtin gene. To implement our diverse research portfolio, we fund and work with academic researcher colleagues around the world. CHDI is not a general research funding body that issues financial grants, nor do we have a research proposal submission cycle. However, we are receptive to novel ideas and will explore new areas of biology that have relevance to HD, particularly when there is either robust human data evidence or the therapeutic approach has disease-modifying potential. Initial proposals are reviewed on a rolling basis by team members. If we are interested in your proposal, then a science director will invite you to submit a full proposal and budget for further review and consideration – see the schematic below. If we are interested in funding your research proposal then typically CHDI and your research institution will enter into a research agreement that defines a detailed project description, milestones with deliverables, and a specific budget. CHDI scientists will be involved in the design and oversight of the project and will work with you to develop a mutually agreeable research plan. The investigator must conduct the research as specified in the contract and deliver progress reports to receive continued support. Under our standard research agreement, the research institution owns the data and
Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Academic Proposals | CHDI Foundation Accelerating Therapeutic Development for Huntington's Disease Research tools & reagents Data sharing & infomatics Preclinical informatics: HDinHD External Partnership Proposals Independent Statistical Standing Committee Clinical outcomes: Rating scales Field guide to HD mouse models HD Therapeutics Conference Data, Reagents, and Biomaterials Sharing Policy Reimbursement of Publication Costs Financial Support for Conferences, Meetings, or Workshops Research tools & reagents Data sharing & infomatics Preclinical informatics: HDinHD External Partnership Proposals Independent Statistical Standing Committee Clinical outcomes: Rating scales Field guide to HD mouse models HD Therapeutics Conference Data, Reagents, and Biomaterials Sharing Policy Reimbursement of Publication Costs Financial Support for Conferences, Meetings, or Workshops CHDI Foundation is exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of individuals with HD.
To prioritize where our resources will be most effective in HD therapeutic development, we have organized our preclinical research programs into four interconnected Thematic Areas that focus on what we consider the most promising therapeutic areas and the means to pharmacologically interrogate them; namely 1) targeting mutant huntingtin DNA, RNA, and protein, 2) targeting somatic instability and mismatch handling and repair mechanisms related to modifier genes, 3) targeting the non-mismatch repair genetic modifiers, and 4) targeting gene editing of the causative triplet repeat mutation in the huntingtin gene.
To implement our diverse research portfolio, we fund and work with academic researcher colleagues around the world. CHDI is not a general research funding body that issues financial grants, nor do we have a research proposal submission cycle.
However, we are receptive to novel ideas and will explore new areas of biology that have relevance to HD, particularly when there is either robust human data evidence or the therapeutic approach has disease-modifying potential. Initial proposals are reviewed on a rolling basis by team members.
If we are interested in your proposal, then a science director will invite you to submit a full proposal and budget for further review and consideration – see the schematic below. If we are interested in funding your research proposal then typically CHDI and your research institution will enter into a research agreement that defines a detailed project description, milestones with deliverables, and a specific budget.
Based on current listing details, eligibility includes: Academic faculty, post-doctoral fellows, and technical staff at research institutions globally. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
View foundation profile, grantmaking history, financials, and key people.
View Foundation ProfileApplication snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Not specified; eligibility guidance Academic faculty, post-doctoral fellows, and technical staff at research institutions globally.
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
CHDI scientists will be involved in the design and oversight of the project and will work with you to develop a mutually agreeable research plan. The investigator must conduct the research as specified in the contract and deliver progress reports to receive continued support.
Under our standard research agreement, the research institution owns the data and intellectual property generated during the project and has the sole and exclusive right to publish. If you would like to apply for research funding from CHDI then please submit a short summary of your proposal to . Typical timeline for proposal consideration : Frequently Asked Questions How long does it take to process an academic research proposal?
Proposals will be assigned to the most relevant Thematic Area and reviewed extensively by our science directors. Initial review usually takes about 4 weeks. If there is mutual interest to enter into a research agreement, a work plan and budget will be drafted by the principal investigator and CHDI science director; agreement execution may take an additional 3-6 months.
Does CHDI give access to materials, reagents, animals, or specialized services? Dependent upon project specifics, CHDI can make certain materials, such as reagents, antibodies, cell lines, animal models, and human biosamples, available to the collaborating academic laboratory, as well as specialized third-party services (e. g.
, HTT assays, sequencing, etc.) What kind of costs are included in CHDI funding? CHDI has a detailed budget policy .
We support standardized full-time employee costs for postdocs and experienced research personnel, consumables, animals, and various other costs, including limited travel, publication, and overhead. CHDI does not normally support graduate students, training, administrative staff, equipment costs, or office supplies. Scientists, patient advocates, journalists and others are invited to contact CHDI for more information.
350 Seventh Ave, Suite 200, New York, NY 10001 6080 Center Drive, Suite 700, Los Angeles, CA 90045 155 Village Boulevard, Suite 200, Princeton, NJ 08540 CHDI is looking to hire qualified individuals for the following positions: Clinical Research Program Manager-Neuroimaging (NJ) Director, Digital Assessment (NJ) System Administrator (NJ) We are an Equal Opportunity Employer.
All persons shall have the opportunity to be considered for employment without regard to their race, color, religion, national origin, ancestry, alienage or citizenship status, age, disability, sex, marital status, veteran status, sexual orientation, genetic information or any other characteristic protected by applicable federal, state or local laws. For all job inquiries contact function show_popup_email() document.
getElementById('popup_email'). style. display="block"; function hide_popup_email() document.
getElementById('popup_email'). style. display="none"; function show_popup_terms() document.
getElementById('terms'). style. display="block"; function hide_popup_terms() document.
getElementById('terms'). style. display="none"; function show_popup_policy() document.
getElementById('policy'). style. display="block"; function hide_popup_policy() document.
getElementById('policy'). style. display="none"; We appreciate any comments or questions on this page—our goal is to make this concise and helpful.
We appreciate any comments or questions on this page—our goal is to make this concise and helpful. Receive spam-free updates from the Huntington's disease research community. Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.
0 Unported License . Receive spam-free updates from the Huntington's disease research community. We reserve the right, in our sole discretion, without any obligation or notice requirement, to suspend or deny your access to the Website for any reason, including for scheduled or unscheduled maintenance, upgrades, improvements or corrections.
You may not attempt to gain unauthorized access to the Website, through hacking, password mining or any other means to circumvent the Website's security procedures. You may not use the Website in any manner that could damage, disable, overburden or impair the Website or any service provided through the Website, or interfere with any other user's use and enjoyment of the Website or any service provided through the Website.
You may not make use of the Website or any service provided through the Website to forge e-mail headers or send bulk unsolicited e-mail messages. Any content we provide or post on the Website may contain errors or inaccuracies, including both typographical and substantive errors.
We reserve the right, in our sole discretion and for any reason, without any obligation or notice requirement, to discontinue, change, improve or correct the content we provide or post on the Website. Any dated content we provide or post on the Website is published as of its date only and we have no responsibility to update or amend any such content.
It is your sole responsibility to evaluate the accuracy, completeness or usefulness of any content provided or posted on the Website. Your Use of Content Contained on the Website Except where otherwise expressly noted or contemplated, all content provided or posted on the Website is being made available to you for the purpose of Huntington's disease related research activities.
Disclaimer of Warranties, Not a Substitute for Medical Advice and Limitation of Liability? THE WEBSITE IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS.
WE AND OUR AFFILIATES AND AGENTS MAKE NO REPRESENTATIONS, WARRANTIES OR CONDITIONS OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OR OTHERWISE, AS TO THE OPERATION OF THE WEBSITE, OR THE ACCURACY, TIMELINESS OR COMPLETENESS OF CONTENT OR SERVICES INCLUDED ON THE WEBSITE.
YOU EXPRESSLY AGREE THAT YOUR USE OF THE WEBSITE AND ANY CONTENT OR SERVICES INCLUDED ON THE WEBSITE IS AT YOUR SOLE RISK.
ALL CONTENT INCLUDED ON THE WEBSITE, SUCH AS TEXT, TREATMENTS, DATA, DOSAGES, OUTCOMES, CHARTS, PATIENT PROFILES, GRAPHICS, PHOTOGRAPHS, IMAGES, ADVICE, MESSAGES, FORUM POSTINGS AND ANY OTHER CONTENT PROVIDED ON THE WEBSITE ARE FOR INFORMATIONAL PURPOSES ONLY AND ARE NOT A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE OR TREATMENT.
YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROVIDER WITH ANY QUESTIONS YOU MAY HAVE REGARDING YOUR HEALTH. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY IN SEEKING IT BECAUSE OF SOMETHING YOU HAVE READ ON THIS WEBSITE. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY.
WE DO NOT RECOMMEND OR ENDORSE ANY SPECIFIC TESTS, PHYSICIANS, PRODUCTS, PROCEDURES, OPINIONS, OR OTHER CONTENT THAT MAY BE MENTIONED ON THE WEBSITE.
YOU EXPRESSLY AGREE THAT NEITHER WE NOR OUR AFFILIATES AND AGENTS ARE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING OR RESULTING FROM YOUR USE OF THE WEBSITE OR ANY CONTENT OR SERVICES INCLUDED ON THE WEBSITE, INCLUDING, BUT NOT LIMITED TO, DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, AND CONSEQUENTIAL DAMAGES. Revision No.
004 (Effective 9/08/2016) Collection of Information and Use If you join our mailing list, we collect some information that can be directly associated with you. We call this information "Personal Information" and it includes your name, title and email address and the name of the company or research institution with which you are affiliated.
You may modify your Personal Information at any time by following the update profile/email address links at the end of any email we send you. By joining our mailing list, you have granted us permission to use your Personal Information to send you emails ("opt-in") relating to our activities and Huntington's disease related research and information.
If you have received an email from us, our records indicate that you joined our mailing list. Because we respect your time and attention, we make every effort to control the frequency of our emails. You may revoke the permission you have given us to use your Personal Information to send you emails ("opt-out") by following the instructions set out in our e-mails.
If you believe you have received unwanted, unsolicited email from us sent via the Website or purporting to be sent via the Website, please forward a copy of that email to > . Privacy and Sharing of Your Personal Information We maintain a variety of physical, electronic and procedural safeguards to protect your Personal Information.
As mentioned above, it is our general policy to restrict access to Personal Information to our employees and agents. The Website may have links to other websites that we do not control. You should know that we have no control over the content, privacy policies or security of any of these websites you elect to visit or interact with.
Furthermore, we are not responsible for the content, privacy policies or security of any of these websites you elect to visit or interact with and you should check those policies on such websites. Browser Information Collected on the Website We log IP addresses, which are the locations of computers or networks on the Internet, and analyze them in order to improve the utility of the Website.
We also collect aggregate numbers of page hits in order to track the popularity of certain pages and improve the utility of the Website. We do not gather, request, record, require, collect or track any users' Personal Information through these processes. Web Beacons can be refused when delivered via email.
If you do not wish to receive Web Beacons via email, you will need to disable HTML images or refuse HTML (select Text only) emails via your email software. Revision No. 003 (Effective 11/01/2015) Click to read a letter from Robert Pacifici, CHDI CSO, regarding COVID-19
© 2026 Granted AI